The article "Romanians Spent Over 7 Billion Euros on Medication in the First Three Months of 2024" discusses the Romanian pharmaceutical market and its challenges. Here's a breakdown of the key points:
Pharmaceutical Market:
Romania's pharmaceutical market reached a yearly value of 7.051 billion euros in the first quarter of 2024, a 13.6% increase compared to the same period in 2023.
Prescription drugs make up 5.169 billion euros of the market, while over-the-counter (OTC) medications account for 1.882 billion euros.
Trade Deficit:
Romania's trade deficit on medication exceeded 5.2 billion euros in 2023 (roughly 18% of the total).
Medicine Withdrawals:
Around 3,000 medications have been withdrawn from Romania in the past five years, including 500 innovative drugs (20% of all innovative medications on the market).
Economic factors were the primary reason for these withdrawals, with production costs exceeding possible selling prices in Romania.
Economic Impact:
A 10% reduction in disability due to illness could lead to annual savings of 982 million euros in Romania.
The innovative pharmaceutical industry contributes over 1 billion euros to the Romanian economy.
Current Issues:
The healthcare insurance system falls short of meeting the population's actual needs.
There's a lack of investor interest in Romania's pharmaceutical industry.
The methodology for setting medication prices across Europe is under review for over four years, with no clear timeframe for completion.
The clawback tax, introduced in 2009 as a temporary measure, collected 17.5 billion lei between 2012 and 2021.
Romania's healthcare spending per capita remains the lowest in the EU (4.5% of GDP in 2024), significantly lower than the European average of 9%.
Future Challenges:
An aging population will put further strain on healthcare expenditures.
Romania has a lower healthy life expectancy at 65 compared to the EU average.
Mortality rates from cancer and cardiovascular diseases are above the EU average.
Proposed Solutions:
Allocate 9% of GDP to healthcare.
Encourage investment in Romania's pharmaceutical industry.
Improve the efficiency of the healthcare insurance system.
Implement policies to combat chronic diseases.
Conclusion:
Romania's healthcare system faces several challenges, including a significant trade deficit on medicines, high drug prices, and limited access to innovative medications. A comprehensive reform of the system is necessary to improve healthcare quality and reduce costs.
Comments